Insider Trading activities of Metabasis Therapeutics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Metabasis Therapeutics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Metabasis Therapeutics Inc since year 2005. Table 2 shows the detailed insider transactions of Metabasis Therapeutics Inc since 2005. The reporting company's ticker symbol is MBRX. The reporting company's CIK number is 1053221.
The total value of stock buying since 2005 is $24,858,897.
The total value of stock sales since 2005 is $428,418.
The total value of stock option exercises since 2005 is $22,019.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Metabasis Therapeutics Inc (MBRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2008-11 6,000 $3,654 0 $0 0 $0
2008-04 2,331,997 $5,456,871 0 $0 0 $0
2007-06 0 $0 13,435 $107,706 0 $0
2007-05 0 $0 300 $2,400 0 $0
2007-04 0 $0 15,600 $126,132 0 $0
2007-02 0 $0 4,000 $32,000 0 $0
2006-12 0 $0 9,000 $72,000 0 $0
2006-11 527,000 $3,775,955 9,500 $76,005 0 $0
2006-06 0 $0 500 $4,175 11,864 $22,019
2006-05 50,000 $401,517 0 $0 0 $0
2006-03 0 $0 1,000 $8,000 0 $0
2005-09 2,598,857 $15,220,900 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Metabasis Therapeutics Inc insiders (MBRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-11-19 Laikind Paul K (Chief Executive Officer) Buy 4,700 .63 2,956
2008-11-18 Laikind Paul K (Chief Executive Officer) Buy 1,300 .54 698
2008-04-16 Rosch Thomas L (10% Owner) Buy 990,816 2.34 2,318,509
2008-04-16 Galakatos Nicholas (10% Owner) Buy 71,866 2.34 168,166
2008-04-16 Oronsky Arnold L (Director) Buy 990,816 2.34 2,318,509
2008-04-16 Evnin Luke (Director) Buy 71,866 2.34 168,166
2008-04-16 Hale David F Buy 10,000 2.34 23,400
2008-04-16 Credit Suisse/ (10% Owner) Buy 196,633 2.34 460,121
2007-06-19 Beck John W (Chief Financial Officer) Sale 3,400 8.05 27,376
2007-06-01 Beck John W (Chief Financial Officer) Sale 10,035 8.00 80,330
2007-05-22 Beck John W (Chief Financial Officer) Sale 300 8.00 2,400
2007-04-25 Beck John W (Chief Financial Officer) Sale 3,300 8.13 26,829
2007-04-24 Baracchini Edgardo Jr (Sr. VP of Business Development) Sale 4,300 8.21 35,303
2007-04-10 Beck John W (Chief Financial Officer) Sale 6,172 8.00 49,376
2007-04-09 Beck John W (Chief Financial Officer) Sale 1,828 8.00 14,624
2007-02-26 Beck John W (Chief Financial Officer) Sale 3,300 8.00 26,400
2007-02-26 Baracchini Edgardo Jr (Sr. VP of Business Development) Sale 700 8.00 5,600
2006-12-05 Beck John W (Chief Financial Officer) Sale 9,000 8.00 72,000
2006-11-27 Beck John W (CFO) Sale 500 8.01 4,005
2006-11-08 Beck John W (Sr. VP, Finance & CFO) Sale 9,000 8.00 72,000
2006-11-03 Credit Suisse/ (10% Owner) Buy 527,000 7.16 3,775,955
2006-06-26 Baracchini Edgardo Jr (Sr. VP, Business Development) Sale 500 8.35 4,175
2006-06-07 Gschwend Heinz W (Director) Option Ex 11,864 1.86 22,019
2006-05-22 Cash Harvey B (10% Owner) Buy 39,836 8.02 319,644
2006-05-19 Cash Harvey B (10% Owner) Buy 5,000 8.10 40,500
2006-05-18 Cash Harvey B (10% Owner) Buy 700 8.10 5,670
2006-05-16 Cash Harvey B (10% Owner) Buy 4,464 8.00 35,703
2006-03-01 Beck John W (Chief Financial Officer) Sale 1,000 8.00 8,000
2005-09-30 Rosch Thomas L (10% Owner) Buy 426,621 5.86 2,499,999
2005-09-30 Galakatos Nicholas (Director) Buy 699,659 5.86 4,100,001
2005-09-30 Oronsky Arnold L (Director) Buy 426,621 5.86 2,499,999
2005-09-30 Evnin Luke (10% Owner) Buy 699,659 5.86 4,100,001
2005-09-30 Credit Suisse First Boston/ (Other) Buy 341,297 5.86 2,000,000
2005-09-07 Gschwend Heinz W (Director) Buy 5,000 4.18 20,900

Insider trading activities including stock purchases, stock sales, and option exercises of MBRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Metabasis Therapeutics Inc (symbol MBRX, CIK number 1053221) see the Securities and Exchange Commission (SEC) website.